$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| BLOCK LISTING INTERIM REVIEW | 01 Jun 2017 |
| DIRECTORATE CHANGE | 31 May 2017 |
| DIRECTOR/PDMR SHAREHOLDING | 24 May 2017 |
| BYDUREON EXSCEL TRIAL MEETS T2D SAFETY OBJECTIVE | 23 May 2017 |
| AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE | 22 May 2017 |
| DIRECTOR/PDMR SHAREHOLDING | 16 May 2017 |
| IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER | 12 May 2017 |
| AZ UPDATES ON TRALOKINUMAB TRIAL IN SEVERE ASTHMA | 10 May 2017 |
| TOTAL VOTING RIGHTS | 02 May 2017 |
| DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL | 02 May 2017 |
| RESULT OF AGM | 27 Apr 2017 |
| ASTRAZENECA: Q1 2017 RESULTS | 27 Apr 2017 |
| TAGRISSO RECEIVES FULL APPROVAL IN THE EU | 25 Apr 2017 |
| TOTAL VOTING RIGHTS | 03 Apr 2017 |
| AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICS | 31 Mar 2017 |
| TAGRISSO (OSIMERTINIB) RECEIVES FDA FULL APPROVAL | 31 Mar 2017 |
| DIRECTOR/PDMR SHAREHOLDING | 28 Mar 2017 |
| DIRECTOR/PDMR SHAREHOLDING | 27 Mar 2017 |
| US FDA ISSUES CRL FOR ZS-9 IN HYPERKALAEMIA | 17 Mar 2017 |
| NOTICE OF AGM | 16 Mar 2017 |
